National Academies Press: OpenBook
« Previous: Appendix B: Glossary and Acronyms
Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×

APPENDIX C
Workshop Agenda

INSTITUTE OF MEDICINE

NATIONAL ACADEMY OF SCIENCES

FORUM ON EMERGING INFECTIONS

Managed Care Systems and Emerging Infections:

Opportunities for Strengthening Surveillance,

Research, and Prevention

March 23–24, 1998

MONDAY, MARCH 23, 1998

8:00 a.m.

Continental Breakfast

8:30

Welcome and Opening Remarks

Joshua Lederberg, Ph.D.

Chair, Forum on Emerging Infections

8:45

Keynote Address

Margaret Hamburg, M.D.

Assistant Secretary for Planning and Evaluation

U.S. Department of Health and Human Services

9:00–11:00

PANEL I: BASIC AND CLINICAL RESEARCH

Moderator: Frederick Sparling, M.D., Forum Member

9:00

AAMC Perspective on Basic and Clinical Research

David Korn, M.D.

Senior Vice President for Biomedical and Health Science Research

Association of American Medical Colleges

Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×

 

Opportunities for Population-Based Clinical Research Using Data from Managed Care Organizations

Frank DeStefano, M.D., M.P.H.

Medical Epidemiologist, Vaccine Safety and Development Activity

National Immunization Program, Centers for Disease Control and Prevention

 

Conducting Clinical Research Within Managed Care Organizations

Walter Stamm, M.D.

Professor of Medicine and Head, Division of Allergy and Infectious Diseases

University of Washington School of Medicine

 

Clinical Research: The Challenge or Promise of Managed Care

Lana Skirboll, Ph.D.

Associate Director, Office of Science Policy

National Institutes of Health

9:45

Discussion

10:50

Break

11:00 a.m.–1:00 p.m. PANEL II: CLINICAL PRACTICE GUIDELINES

Moderator: Vincent Ahonkhai, M.D., Forum Member

11:00

Making Guidelines Instrumental: Theory versus Practice

Richard E. Dixon, M.D.

Medical Director, National Independent Practice Association Coalition

 

Realities of Implementing Guidelines

Nora Morris, M.A.

Assistant Director/Senior Analyst, Healthcare Education and Research Foundation, Inc.

 

Clinical Practice Guidelines for Emerging Infections and Managed Care

Anne Schuchat, M.D.

Chief, Childhood and Respiratory Diseases Branch

Bacterial and Mycotic Disease Division, National Center for Infectious Diseases

Centers for Disease Control and Prevention

Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×

11:30

Discussion and Working Lunch

1:00–3:00 p.m. PANEL III: SURVEILLANCE AND MONITORING

Moderator: Carlos Lopez, Ph.D., Forum Member

1:00

Collaborative Surveillance Efforts and Monitoring of Data

Richard Platt, M.D.

Director of Research, Harvard Pilgrim Health Care of New England

 

LDS Hospital's System

John Burke, M.D.

Department of Clinical Epidemiology, LDS Hospital

 

An Employer's Perspective

Thomas Davies, M.P.A., J.D.

Manager of Managed Care, GTE Corporation

 

Laboratory-Based Reporting and Managing Encounter-Level Data

Richard E. Dixon, M.D.

Medical Director, National Independent Practice Association

 

Laboratory-Based Reporting Issues

Robert Rubin, M.D.

President and Chief Operating Officer

The Lewin Group

 

Surveillance and Monitoring: Issues at the Legal Interface

René Bowser, J.D.

Georgetown University Law Center

 

Managed Care and Infectious Disease Surveillance: Opportunities for Collaboration

Denise Koo, Ph.D.

Director, Division of Public Health Surveillance and Informatics

Epidemiology Program Office, Centers for Disease Control and Prevention

1:40

Discussion

2:50

Break

Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×

3:00–4:30 p.m. PANEL IV: EDUCATION AND OUTREACH

Moderator: Renu Gupta, M.D., Forum Member

3:00

Coordinating Health Plan Research and Educational Efforts

Richard Platt, M.D.

Director of Research, Harvard Pilgrim Health Care of New England

 

Perspective on Managed Care Systems' Impact on Education and Outreach from the National Center for Infectious Diseases

Ben Schwartz, M.D.

Deputy Director, Epidemiology and Surveillance Division

National Center for Infectious Diseases, Centers for Disease Control and Prevention

 

Education and Outreach Perspectives by the National Institute of Allergy and Infectious Diseases

Karl Western

Assistant Director for International Research

National Institute of Allergy and Infectious Diseases

National Institutes of Health

 

Managed Care Systems and Emerging Infections: Education and Outreach

William Baine, M.D.

Center for Cost and Financing Studies

Center for Outcomes and Effectiveness Research

Agency for Health Care Policy and Research

3:30

Discussion

4:30

Adjournment

TUESDAY, MARCH 24, 1998

8:00 a.m.

Continental Breakfast

8:30–10:00 a.m. PANEL V: DRUG FORMULARIES

Moderator: David Shlaes, M.D., Ph.D., Forum Member

Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×

8:30

Regulatory Issues

Laurie Burke, R.Ph., M.P.H.

Chief of Managed Care Outcome and Labeling, Drug Marketing, Advertising, and Communication Division

Center for Drug Evaluation and Research

U.S. Food and Drug Administration

 

Relationship Between Managed Care Formularies and Treatment Outcomes

Susan Horn, Ph.D.

Senior Scientist, Institute for Clinical Outcomes Research

Vice President of Research for International Severity Information Systems

Professor of Medical Informatics, University of Utah School of Medicine

 

Bacterial Resistance, the Antibiotic Formulary, and Other Management Strategies

Jerome Schentag, Pharm. D.

Director, Clinical Pharmacokinetics Laboratory

Millard Fillmore Health System

Professor of Pharmaceutics and Pharmacy

State University of New York at Buffalo

 

The Economics of Restrictions on Pharmaceuticals

Douglas L. Cocks, Ph.D.

Senior Research Scientist for Health Economics

Eli Lilly & Company

9:00

Discussion

9:50

Break

10:00 a.m.–12:00 noon GENERAL DISCUSSION

 

General Discussion

Moderator: Joshua Lederberg, Ph.D., Forum Chair

10:00

Summary of Sessions by Panel Moderators

Panel I: Basic and Clinical Research Frederick Sparling, M.D.

Panel II: Clinical Practice Guidelines Vincent Ahonkhai, M.D.

Panel III: Surveillance and Monitoring Carlos Lopez, Ph.D.

Panel IV: Education and Outreach Renu Gupta, M.D.

Panel V: Drug Formularies David Shlaes, M.D., Ph.D.

Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×

11:00 a.m.

Discussion

12:00 noon

Closing Remarks

Joshua Lederberg, Ph.D.

Chair, Forum on Emerging Infections

12:15 p.m.

Adjournment

Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×
Page97
Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×
Page98
Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×
Page99
Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×
Page100
Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×
Page101
Suggested Citation:"Appendix C: Workshop Agenda." Institute of Medicine. 2000. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/9760.
×
Page102
Next: Appendix D: Forum Member and Staff Biographies »
Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention: Workshop Summary Get This Book
×
Buy Paperback | $37.00 Buy Ebook | $29.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

This workshop summary report examines how the managed care revolution has created both problems and opportunities in the fight against infectious diseases. It highlights ways in which managed care systems can aid research, develop clinical guidelines, manage the use of antibiotics, support public education efforts, and monitor the spread of emerging infections and microbial resistance.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!